Roivant Sciences Ltd.

NASDAQ:ROIV

11.21 (USD) • At close June 4, 2025
Bedrijfsnaam Roivant Sciences Ltd.
Symbool ROIV
Munteenheid USD
Prijs 11.21
Beurswaarde 7,620,625,260
Dividendpercentage 0%
52-weken bereik 8.73 - 13.055
Industrie Biotechnology
Sector Healthcare
CEO Mr. Matthew Gline
Website https://roivant.com

An error occurred while fetching data.

Over Roivant Sciences Ltd.

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis,

Vergelijkbare Aandelen

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

14.42 USD

Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc.

PCRX

26.98 USD

Privia Health Group, Inc. logo

Privia Health Group, Inc.

PRVA

23.01 USD

LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

5.95 USD

STAAR Surgical Company logo

STAAR Surgical Company

STAA

16.67 USD

Telesis Bio, Inc. logo

Telesis Bio, Inc.

TBIO

0.285 USD

ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc.

ACAD

21.77 USD

Neogen Corporation logo

Neogen Corporation

NEOG

4.96 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)